Factors predicting the efficacy of gefitinib in patients with advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Kishi, K [1 ]
Homma, S [1 ]
Miyamoto, A [1 ]
Sakamoto, S [1 ]
Motoi, N [1 ]
Yoshimura, K [1 ]
机构：
[1] Toranomon Gen Hosp, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：644S / 644S
页数：1
相关论文
共 50 条
  • [1] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    [J]. LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [2] The results of the treatment with gefitinib (Iressa) in 89 patients with advanced non-small cell lung cancer (NSCLC)
    Skrickova, J
    Tomiskova, M
    Svobodnik, A
    Kaplanova, J
    Kadlec, B
    Palkova, I
    Babickova, L
    Stratil, D
    Nebesky, T
    [J]. LUNG CANCER, 2005, 49 : S376 - S376
  • [3] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)
    Kim, Se Hyun
    Shim, Hyo Sup
    Cho, Jaeho
    Jeong, Jae Heon
    Kim, Sun Mi
    Hong, Yun Kyoung
    Sung, Ji Hee
    Ha, Sang-Jun
    Kim, Hye Ryun
    Chang, Hyun
    Kim, Joo Hang
    Tania, Crombet
    Cho, Byoung Chul
    [J]. LUNG CANCER, 2013, 79 (03) : 270 - 275
  • [4] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC).
    Kim, Han Sang
    Cho, Byoung Chul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [6] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    [J]. INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
  • [7] The BC Cancer Agency experience with gefitinib in advanced non-small cell lung cancer (NSCLC)
    Ho, C
    Murray, N
    Melosky, B
    Laskin, J
    Anderson, H
    Karim, RR
    Hamata, L
    Bebb, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 220S - 220S
  • [8] Efficacy and safety of domestic and imported gefitinib in patients with advanced non-small cell lung cancer
    Cheng, Huawei
    Liu, Hongyue
    Du, Qiong
    Zhang, Hui
    Zhang, Xiaodan
    Wang, Yangkui
    Shao, Jingjing
    Yang, Feng
    Zhang, Bo
    Shi, Jing
    Liu, Yuguo
    Wu, Nan
    Xu, Silu
    Wei, Qing
    Sun, Yancai
    Zhai, Qing
    Yu, Bo
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 10 - 15
  • [9] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Meng-zhao
    [J]. 中华医学杂志(英文版), 2006, (01) : 63 - 68
  • [10] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Mengzhao LI Longyun WANG Shulan ZHANG Xiaotong ZHONG Wei and ZHANG LiDepartment of Respiratory Diseases Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China
    [J]. Chinese Medical Journal., 2006, (01) - 68
12345